Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closed to Accrual

Canadian Cancer Trials Group IND.188 was recently closed to accrual.

IND.188 - A Phase I Clinical and Pharmacokinetic Study of SB939 in Patients with Advanced Cancer -- was closed to accrual 16 March 2010. A total of 38 evaluable patients were accrued to 7 dose levels. We hope to publish the Final Report this spring.